SPRY4 and melanoma: Significantly higher SPRY4‐IT1 relative expression was observed in melanoma patients (mean ΔCT: −5.12 ± 0.62) as compared to controls (mean ΔCT: −4.01 ± 0.34, P < 0.001; Fig. 1).